Orthopaedic Industry News & Orthopaedic Company News | Orthogate Professionals

The global neurostimulation device market was valued at $5,656.1 million in 2015, and it is expected to grow at a CAGR of 12.9% during the period 2016 - 2022.

The increasing demand for miniaturized connectors, expanding medical devices industry, surging aging population, and rising prevalence of chronic diseases are some of the major reasons behind for the prosperity of the medical connectors market. In 2016, the market attained a size of $1.9 billion, and it is projected to generate a revenue of $2.8 billion by 2023, progressing at a CAGR of 6.3% during the forecast period (2017–2023). Medical connectors are used to latch or un-latch the tubing in medical devices and connect such devices and systems for transferring signals, data, media or power.

The use of customized orthopedic orthotic devices has increased considerably owing to their advantages such as these are specifically manufactured for a patient as per their measurements which means they are more comfortable than other devices. This in turn is expected to stimulate the market for orthotic devices 

The geographical segmentation of the global orthobiologics market includes North America, Europe, Asia-Pacific and Rest of the World (RoW). 

The surgical site infection market is expected to witness the fastest growth in APAC, at a CAGR of 7.7% by P&S Intelligence.

Global medical bionics market is forecasted to generate a revenue of $28.1 billion by 2023, according to P&S Market Research.

The global foot and ankle devices market is growing due to technological advancement of ankle and foot devices, and increasing number of free trade agreements. These devices are becoming lighter, stronger, and limits additional amount of energy applied by the organ, thus leading to increased demand for these device.

Rapid rate of the co-morbidities that include obesity and diabetes have been adding to the risk of degenerative joint diseases, especially in the older population. With young people engaging more in sports and fitness activities, relevant injuries are also increasing in number. This has further created demand for orthopedic implants worldwide.

OrthoXel is a specialist orthopaedic trauma company, using innovative engineering design to evolve truly next generation fracture fixation devices. OrthoXel is delighted to announce that following United States FDA 510k and CE mark clearance for the Apex Tibial Nailing System, the new Apex Femoral Nailing System has been granted European CE Mark, following the FDA 510(k) earlier in the year.